Peptide questions · Vitamin D3 + K2
Vitamin D3 + K2 side effects: what studies and users report
Reviewed Evidence: EstablishedPublished by PepVault
The library lists two common side effects for Vitamin D3 + K2, no common side effects at the trial doses and high blood calcium with far too much vitamin D (rare; toxicity), and a safety note; the library’s evidence on it includes controlled trials in people.
Its safety note opens: Vitamins sold as supplements.
What is commonly reported with Vitamin D3 + K2
- No common side effects at the trial doses
- High blood calcium with far too much vitamin D (rare; toxicity)
Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.
| Effect | Also listed for (of 37) |
|---|---|
| No common side effects at the trial doses | None: listed for Vitamin D3 + K2 alone |
| High blood calcium with far too much vitamin D (rare; toxicity) | None: listed for Vitamin D3 + K2 alone |

Which Vitamin D3 + K2 side effects the longevity group shares
Across the 38 longevity compounds in the library, the effects listed most often are usually none above placebo in the trials (4 of 38), acne (2 of 38), not well characterised in people yet (2 of 38) and rare liver injury (supplement-associated) (2 of 38). None of Vitamin D3 + K2’s 2 listed effects appears for another longevity compound: no common side effects at the trial doses and high blood calcium with far too much vitamin D (rare; toxicity) are its own in the library.
What the Vitamin D3 + K2 safety notes say
The library’s safety note
Vitamins sold as supplements. EFSA sets the upper level for vitamin D at 100 mcg (4,000 IU) a day for adults; there is no upper level for vitamin K. Above that level, a 3-year Canadian trial found bone density fell slightly more at 4,000 and 10,000 IU a day than at 400 IU. Vitamin D toxicity, rare and mostly from far too much, raises blood calcium and can harm the kidneys. Vitamin K matters most for anyone on warfarin or a similar blood thinner: even 10–20 mcg a day of MK-7 shifted the INR in volunteers, so K2 is started, stopped or changed only with the prescriber. Discuss with your clinician.
The library’s interaction note
Warfarin is a vitamin K antagonist: its label says more vitamin K lowers its effect and asks for a steady vitamin K intake, and in a study as little as 10 mcg of MK-7 a day lowered the INR in at least 40% of volunteers on a similar drug. Discuss every medication with your clinician.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Where the Vitamin D3 + K2 reports come from
The library rates the evidence on Vitamin D3 + K2 as established: clinical trials or FDA-approved use exist.
Of the library’s 5 research notes on Vitamin D3 + K2, 5 rest on randomized trials.
So Vitamin D3 + K2 has controlled trials in people to set its listed effects against.
Questions people ask
What are the side effects of Vitamin D3 + K2?
The library lists two common side effects for Vitamin D3 + K2, no common side effects at the trial doses and high blood calcium with far too much vitamin D (rare; toxicity), and a safety note; the library’s evidence on it includes controlled trials in people.
Do Vitamin D3 + K2’s side effects come from human studies?
The library rates the evidence on Vitamin D3 + K2 as established, and the library’s evidence on it includes controlled trials in people.
Which Vitamin D3 + K2 side effects are its own?
Among the longevity compounds, the library lists no common side effects at the trial doses and high blood calcium with far too much vitamin D (rare; toxicity) for Vitamin D3 + K2 alone.
Does Vitamin D3 + K2 interact with other medicines?
The library’s interaction note on Vitamin D3 + K2 begins: Warfarin is a vitamin K antagonist: its label says more vitamin K lowers its effect and asks for a steady vitamin K intake, and in a study as little as 10 mcg of MK-7 a day lowered the INR in at least 40% of volunteers on a similar drug.